clinical trial · NCT07174401
Rocklatan Retinal Perfusion OCT Study
Oregon Health and Science University·phase4·not yet recruiting·n = 30
GlaucomaRocklatan eye drops will be instilled nightly in one eye diagnosed with glaucoma for up to 12 months.Two optical coherence tomography (OCT) devices will be used to assess blood flow changes.
brief summary
The main purpose of this study is to learn more about how Rocklatan eye drops affects blood flow in the eye. The secondary purpose is to see if our study devices can detect changes in blood flow before and after instillation of Rocklatan.
started
Jan 1, 2026
primary completion
Dec 1, 2026
completion
Oct 1, 2027
last updated
Dec 24, 2025
official title
Rocklatan Trial With Optical Coherence Tomography Study of Retinal Perfusion
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol